Literature DB >> 25524583

The interplay between p66Shc, reactive oxygen species and cancer cell metabolism.

Magdalena Lebiedzinska-Arciszewska1, Monika Oparka, Ignacio Vega-Naredo, Agnieszka Karkucinska-Wieckowska, Paolo Pinton, Jerzy Duszynski, Mariusz R Wieckowski.   

Abstract

The adaptor protein p66Shc links membrane receptors to intracellular signalling pathways and has the potential to respond to energy status changes and regulate mitogenic signalling. Initially reported to mediate growth signals in normal and cancer cells, p66Shc has also been recognized as a pro-apoptotic protein involved in the cellular response to oxidative stress. Moreover, it is a key element in processes such as cancer cell proliferation, tumor progression, metastasis and metabolic reprogramming. Recent findings on the role of p66Shc in the above-mentioned processes have been obtained through the use of various tumor cell types, including prostate, breast, ovarian, lung, colon, skin and thyroid cancer cells. Interestingly, the impact of p66Shc on the proliferation rate was mainly observed in prostate tumors, while its impact on metastasis was mainly found in breast cancers. In this review, we summarize the current knowledge about the possible roles of p66Shc in different cancers.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Cancer; cancer metabolism; p66Shc; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 25524583     DOI: 10.1111/eci.12364

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.

Authors:  Ling Zhang; Shengtao Zhu; Xuesen Shi; Weihong Sha
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  P66Shc-SIRT1 Regulation of Oxidative Stress Protects Against Cardio-cerebral Vascular Disease.

Authors:  Xiangyi Kong; Jian Guan; Jun Li; Junji Wei; Renzhi Wang
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

3.  p66Shc signaling does not contribute to tubular damage induced by renal ischemia-reperfusion injury in rat.

Authors:  Bradley Miller; Kevin Regner; Andrey Sorokin
Journal:  Biochem Biophys Res Commun       Date:  2022-03-03       Impact factor: 3.575

4.  The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.

Authors:  Tobias Furlan; Sana Khalid; Anh-Vu Nguyen; Julia Günther; Jakob Troppmair
Journal:  Mol Oncol       Date:  2018-05-05       Impact factor: 6.603

5.  Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells.

Authors:  A Conte; C Procaccini; P Iannelli; A Kisslinger; F De Amicis; G M Pierantoni; F P Mancini; G Matarese; D Tramontano
Journal:  Transl Med UniSa       Date:  2016-01-31

6.  Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.

Authors:  Qing-Lin He; Shan-Yu Qin; Lin Tao; Hong-Jian Ning; Hai-Xing Jiang
Journal:  Oncol Lett       Date:  2019-10-04       Impact factor: 2.967

7.  p66ShcA functions as a contextual promoter of breast cancer metastasis.

Authors:  Kyle Lewis; Alex Kiepas; Jesse Hudson; Julien Senecal; Jacqueline R Ha; Elena Voorand; Matthew G Annis; Valerie Sabourin; Ryuhjin Ahn; Rachel La Selva; Sébastien Tabariès; Brian E Hsu; Matthew J Siegel; Matthew Dankner; Eduardo Cepeda Canedo; Mathieu Lajoie; Ian R Watson; Claire M Brown; Peter M Siegel; Josie Ursini-Siegel
Journal:  Breast Cancer Res       Date:  2020-01-15       Impact factor: 6.466

8.  circ-PRKCB acts as a ceRNA to regulate p66Shc-mediated oxidative stress in intestinal ischemia/reperfusion.

Authors:  Dongcheng Feng; Zhecheng Wang; Yan Zhao; Yang Li; Deshun Liu; Zhao Chen; Shili Ning; Yan Hu; Jihong Yao; Xiaofeng Tian
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

9.  Actin Modulation Regulates the Alpha-1-Syntrophin/p66Shc Mediated Redox Signaling Contributing to the RhoA GTPase Protein Activation in Breast Cancer Cells.

Authors:  Roshia Ali; Hilal Ahmad Mir; Rabia Hamid; Basharat Bhat; Riaz A Shah; Firdous A Khanday; Sahar Saleem Bhat
Journal:  Front Oncol       Date:  2022-02-21       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.